Anthroposophic Therapy for Anxiety Disorders: A Two-year Prospective Cohort Study in Routine Outpatient Settings

H. Hamre, C. Witt, G. Kienle, A. Glockmann, R. Ziegler, S. Willich, H. Kiene
{"title":"Anthroposophic Therapy for Anxiety Disorders: A Two-year Prospective Cohort Study in Routine Outpatient Settings","authors":"H. Hamre, C. Witt, G. Kienle, A. Glockmann, R. Ziegler, S. Willich, H. Kiene","doi":"10.4137/CMPsy.S2791","DOIUrl":null,"url":null,"abstract":"Background and Methods Anthroposophic treatment for anxiety disorders includes special artistic and physical therapies and special medications. We conducted a prospective cohort study of 64 consecutive adult outpatients starting anthroposophic treatment for anxiety disorders under routine conditions. Main outcomes were Anxiety Severity (physician and patient ratings 0–10), Self-rating Anxiety Scale (0–100), Center for Epidemiological Studies Depression Scale, German version (CES-D, 0–60), and SF-36 Mental Component Summary. Results Mean age was 42.3 years. Most frequent diagnoses were generalized anxiety disorder (44% of patients, n = 28/64) and panic disorder (39%). Median disease duration was 4.5 years. The anthroposophic treatment modalities used were medications (56% of patients), eurythmy therapy (41%), art therapy (30%), and rhythmical massage therapy (3%). Median number of eurythmy/art/massage sessions was 12, median therapy duration was 120 days. From baseline to six-month follow-up, all outcomes improved significantly; average improvements were: Physician-rated Anxiety Severity 3.60 points (95% confidence interval 2.97–4.22, p < 0.001), patient-rated Anxiety Severity 3.50 (2.88–4.12, p < 0.001), Self-rating Anxiety Scale 11.88 (7.70–16.05, p < 0.001), CES-D 8.79 (5.61–11.98, p < 0.001), and SF-36 Mental Component 9.53 (5.98–13.08, p < 0.001). All improvements were maintained until last follow-up after 24 months. Conclusions Patients with anxiety disorders under anthroposophic treatment had long-term improvements of symptoms and quality of life.","PeriodicalId":10437,"journal":{"name":"Clinical Medicine Insights: Psychiatry","volume":"7 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2009-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Medicine Insights: Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4137/CMPsy.S2791","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12

Abstract

Background and Methods Anthroposophic treatment for anxiety disorders includes special artistic and physical therapies and special medications. We conducted a prospective cohort study of 64 consecutive adult outpatients starting anthroposophic treatment for anxiety disorders under routine conditions. Main outcomes were Anxiety Severity (physician and patient ratings 0–10), Self-rating Anxiety Scale (0–100), Center for Epidemiological Studies Depression Scale, German version (CES-D, 0–60), and SF-36 Mental Component Summary. Results Mean age was 42.3 years. Most frequent diagnoses were generalized anxiety disorder (44% of patients, n = 28/64) and panic disorder (39%). Median disease duration was 4.5 years. The anthroposophic treatment modalities used were medications (56% of patients), eurythmy therapy (41%), art therapy (30%), and rhythmical massage therapy (3%). Median number of eurythmy/art/massage sessions was 12, median therapy duration was 120 days. From baseline to six-month follow-up, all outcomes improved significantly; average improvements were: Physician-rated Anxiety Severity 3.60 points (95% confidence interval 2.97–4.22, p < 0.001), patient-rated Anxiety Severity 3.50 (2.88–4.12, p < 0.001), Self-rating Anxiety Scale 11.88 (7.70–16.05, p < 0.001), CES-D 8.79 (5.61–11.98, p < 0.001), and SF-36 Mental Component 9.53 (5.98–13.08, p < 0.001). All improvements were maintained until last follow-up after 24 months. Conclusions Patients with anxiety disorders under anthroposophic treatment had long-term improvements of symptoms and quality of life.
焦虑障碍的人智疗法:常规门诊设置的两年前瞻性队列研究
背景与方法焦虑障碍的人智治疗包括特殊的艺术、物理治疗和特殊的药物治疗。我们进行了一项前瞻性队列研究,64名连续的成人门诊患者在常规条件下开始对焦虑症进行人智疗法治疗。主要结果为焦虑严重程度(医生和患者评分0-10)、焦虑自评量表(0-100)、流行病学研究中心抑郁量表,德文版本(CES-D, 0-60)和SF-36心理成分摘要。结果平均年龄42.3岁。最常见的诊断是广泛性焦虑症(44%的患者,n = 28/64)和恐慌症(39%)。中位病程为4.5年。使用的人智治疗方式是药物治疗(56%的患者)、心律治疗(41%)、艺术治疗(30%)和节律按摩治疗(3%)。心律/艺术/按摩疗程中位数为12次,治疗持续时间中位数为120天。从基线到6个月随访,所有结果均显著改善;平均改善为:医生评定焦虑严重程度3.60分(95%可信区间2.97-4.22,p < 0.001),患者评定焦虑严重程度3.50分(2.88-4.12,p < 0.001),自评焦虑量表11.88分(7.70-16.05,p < 0.001), CES-D 8.79分(5.61-11.98,p < 0.001), SF-36心理成分9.53分(5.98-13.08,p < 0.001)。所有改善一直保持到24个月后的最后一次随访。结论经人智疗法治疗的焦虑症患者症状和生活质量均有长期改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信